SCHEMBL30801773

SCHEMBL30801773

Cc1nc(C2CCCCC2)sc1N1CCN2CCNC[C@@H]2C1=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801842 0.87
SCHEMBL30801779 0.82
SCHEMBL23574071 0.78 USP30 (0.30) ALDH1A1TP53
SCHEMBL23574075 0.78 USP30 (0.30) ALDH1A1TP53
SCHEMBL30801749 0.78 MAP4K3 (0.34)
SCHEMBL30801814 0.76
SCHEMBL30801766 0.75
SCHEMBL30801803 0.75
SCHEMBL23113756 0.74 CHRNA7 (0.34)
SCHEMBL30801800 0.74 CHRNA7 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 EP claimed